$15.73
Today
as of Aug 5, 16:52 ET
Last 30 days
Recent Press Releases & News
NEO: Raising target price to $17.00
NeoGenomics, Inc. (NEO) Hit a 52 Week High, Can the Run Continue?
NeoGenomics (NEO) Following Q2 Profit And Raised Outlook, Is Fair Value Already Priced In?
Overview
52-week range
$4.72
$14
100% of range
Avg surprise (last 2)
+20.8%
Avg reaction (last 1)
-34.0%
0% positive
Latest IV / EM
78%
EM ±13.0% · $16 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jul 29, 2025 | Jun/2025 | $-0.06 | $-0.07 | +14.3% | — | — | earnings |
| Tue Apr 29, 2025 | Mar/2025 | $-0.08 | $-0.11 | +27.3% | — | -34.0% | earnings |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | $81M | — | $80M | $77M | $73M | — | $75M | $72M |
| Operating income | $-18M | — | $-27M | $-48M | $-28M | — | $-21M | $-22M |
| Net income | $-17M | — | $-27M | $-45M | $-26M | — | $-18M | $-19M |
| EPS (diluted) | — | — | — | — | — | — | — | — |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $146M | $160M | $164M | $155M | $346M | $367M | $362M | $355M |
| Inventory | $30M | $29M | $28M | $34M | $30M | $27M | $24M | $23M |
| Total current assets | $374M | $376M | $382M | $393M | $574M | $596M | $590M | $584M |
| Total assets | $1.35B | $1.36B | $1.37B | $1.39B | $1.60B | $1.64B | $1.64B | $1.64B |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $518M | $523M | $536M | $540M | $713M | $736M | $733M | $727M |
| Total equity | $829M | $837M | $838M | $854M | $888M | $902M | $908M | $916M |